Advertisement

Prognosis of Hepatocellular Carcinoma

  • Kunio Okuda
  • Kunihiko Ohnishi

Abstract

Of the various types of solid cancer, hepatocellular carcinoma (HCC) is perhaps the most difficult to treat because of the frequently associated cirrhosis [1–5]. Although there are large differences in its global incidence and in the frequency of coexisting cirrhosis that varies with the ethnic group [6–9], the basic clinical features and the generally poor prognosis are the same regardless of race and place. The survival times of patients with HCC as a whole have been estimated to be several months at most [10–13] with rare exceptions of long survival [14–16] and spontaneous regression [17, 18].

Keywords

Hepatic Resection Systemic Chemotherapy Transcatheter Arterial Embolization Cellular Carcinoma Hepatic Artery Infusion Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver. A study of 100 cases among 48 900 necropsies. Cancer 7:462–503PubMedCrossRefGoogle Scholar
  2. 2.
    Peters RL (1976) Pathology of hepatocellular carcinoma. In: Okuda K, Peters RL (eds). Hepatocellular carcinoma. Wiley, New York, pp 107–158Google Scholar
  3. 3.
    Nakashima T, Okuda K, Kojiro M, Jimi A, Yamaguchi K, Sakamoto S, Ikari T (1983) Pathology of hepatocellular carcinoma in Japan. 232 consecutive cases, autopsied in 10 years. Cancer 51: 863–877PubMedCrossRefGoogle Scholar
  4. 4.
    Mori W (1967) Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati. Cancer 20:627–631PubMedCrossRefGoogle Scholar
  5. 5.
    Anthony PP (1973) Primary carcinoma of the liver. A study of 282 cases in Ugandan Africans. J Pathol Bacteriol 110: 37–49CrossRefGoogle Scholar
  6. 6.
    Munoz N, Linsell A (1982) Epidemiology of primary liver cancer. In: Correa P, Haenszel W (eds) Epidemiology of cancer of the digestive tract. Nijhoff, The Hague, pp 161–195CrossRefGoogle Scholar
  7. 7.
    Kew MC, Geddes EW (1982) Hepatocellular carcinoma in rural southern African blacks. Medicine 61:98–108PubMedCrossRefGoogle Scholar
  8. 8.
    Okuda K, Mackay I (1982) Hepatocellular carcinoma. A series of workshops on the biology of human cancer, report no. 17. UICC, GenevaGoogle Scholar
  9. 9.
    Li FP, Shiang EL (1980) Cancer mortality in China. J Natl Cancer Inst 65:217–221PubMedGoogle Scholar
  10. 10.
    EL-Domeiri AL, Huvos AG, Goldsmith HS, Foote FW Jr (1971) Primary malignant tumors of the liver. Cancer 27:7–11PubMedCrossRefGoogle Scholar
  11. 11.
    Primack A, Vogel CL, Kyalwazi SK, Ziegler JL, Simon R, Anthony PP (1975) A staging system for hepatocellular carcinoma: Prognostic factors in Ugandan patients. Cancer 35:1357–1364PubMedCrossRefGoogle Scholar
  12. 12.
    Falkson G, Moertel CG, Lavin P, Pretorius FJ, Carbone PP (1978) Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial. Cancer 42:2149–2156PubMedCrossRefGoogle Scholar
  13. 13.
    Lai CL, Lam KC, Wong KP, Wu PC, Todd D (1981) Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong Kong. Cancer 47:2746–2755PubMedCrossRefGoogle Scholar
  14. 14.
    Okuda K (1976) Clinical aspects of hepatocellular carcinoma: Analysis of 134 cases. In: Okuda K, Peters RL (eds) Wiley, New York, pp 387–436Google Scholar
  15. 15.
    Berman MM, Libbey NP, Foster JH (1980) Hepatocellular carcinoma: Polygonal cell type with fibrous stroma. An atypical variant with a favorable prognosis. Cancer 46:1448–1455PubMedCrossRefGoogle Scholar
  16. 16.
    Yoshida T, Okazaki N, Yoshino M, Kitaoka H, Hirohashi S, Shimozato Y (1982) Minute hepatocellular carcinoma without appreciable change in size for 7 years: A case report. Cancer 49:1491–1495PubMedCrossRefGoogle Scholar
  17. 17.
    Gottfried E, Steller R, Paronetto F, Lieber CS (1982) Spontaneous regression of hepatocellular carcinoma. Gastroenterology; 82:114–710Google Scholar
  18. 18.
    Lam KC, Ho JCI, Yeung RTT (1982) Sponta-neous regression of hepatocellular carcinoma. Cancer 50: 332–336PubMedCrossRefGoogle Scholar
  19. 19.
    Okuda K, Nakashima T, Obata H, Kubo Y (1977) Clinicopathological studies of minute hepatocellular carcinoma: Analysis of 20 cases, including 4 with hepatic resection. Gastroenterology 73: 109–115PubMedGoogle Scholar
  20. 20.
    Chen DS, Sheu JC, Sung JL, Lai MY, Lee CS, Su CT, Tsang YM, How SW, Wang TH, Yu JY, Yang TH, Wang CY Hsu CY (1982) Small hepatocellular carcinoma: A clinicopathological study in thirteen patients. Gastroenterology 83: 1109–1119PubMedGoogle Scholar
  21. 21.
    Shinagawa T, Ohto M, Kimura K, Tsunetomi S, Morita M, Saisho H, Tsuchiya Y, Saotome N, Karasawa E, Miki M, Ueno T, Okuda K (1984) Diagnostic and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasonography: A study of 51 patients. Gastroenterology 86:496–502Google Scholar
  22. 22.
    Okazaki N, Yoshino M, Yoshida T, Ohkura H, Moriyama N, Matsue K (1981) Growth speed of hepatocellular carcinoma and early diagnosis. Acta Hepatol Jpn 22:1742 (in Japanese)Google Scholar
  23. 23.
    Yoshino M (1983) Growth kinetics of hepatocellular carcinoma. Jpn J Clin Oncol 13:45–52PubMedGoogle Scholar
  24. 24.
    Mashima Y (1984) Growth rate of hepatocellular carcinoma by ultrasonography and its clinical significance. Acta Hepatol Jpn 25:754–765 (in Japanese)CrossRefGoogle Scholar
  25. 25.
    Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Hsu HC, Chang CN, Yang PC, Wang TH, Lin JT, Lee CZ (1985) Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 89:259–266PubMedGoogle Scholar
  26. 26.
    Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, Morita M, Saisho H, Tsuchiya Y, Okuda K (1986) Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 90:289–298PubMedGoogle Scholar
  27. 27.
    Berman C (1951) Primary carcinoma of the liver. Lewis, London, pp 46–48Google Scholar
  28. 28.
    Halpert B, Erickson EE (1955) Carcinoma of the liver. A study of twenty-eight cases. Cancer 8: 992–1002PubMedCrossRefGoogle Scholar
  29. 29.
    Vogel CL, Linsell CA (1972) International symposium on hepatocellular carcinoma, Kampala, Uganda (July 1971). J Natl Cancer Inst 48:567–571Google Scholar
  30. 30.
    Steiner PE (1960) Cancer of the liver and cirrhosis in trans-Saharan Africa and the United States of America. Cancer 13:1085–1166CrossRefGoogle Scholar
  31. 31.
    Kew MC (1981) Clinical, pathologic, and etiologic heterogeneity in hepatocellular carcinoma: Evidence from southern Africa. Hepatology 1: 366–369PubMedCrossRefGoogle Scholar
  32. 32.
    Okuda K, Peters RL, Simson I (1984) Gross anatomical features of hepatocellular carcinoma from three disparate geographic areas: Proposal of new classification. Cancer 54:2165–2173PubMedCrossRefGoogle Scholar
  33. 33.
    Cochrane AMG, Murray-Lyon IM, Brinkley DM, Williams R (1977) Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma. Cancer 40:609–614PubMedCrossRefGoogle Scholar
  34. 34.
    Almersjo, O, Bengmark S, Rudenstam CM, Hafstrom L, Nilsson LAV (1972) Evaluation of hepatic dearterialization in primary and secondary cancer of the liver. Am J Surg 124: 5–9PubMedCrossRefGoogle Scholar
  35. 35.
    Idhe DC, Sherlock P, Winaxer SJ, Fortner JG (1974) Clinical manifestations of hepatoma: A review of 6 years’ experience at a cancer hospital. Am J Med 56:83–91CrossRefGoogle Scholar
  36. 36.
    Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 56:918–928PubMedCrossRefGoogle Scholar
  37. 37.
    Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M (1983) Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in cases of resection following embolization. Radiology 147:401–405PubMedGoogle Scholar
  38. 38.
    Yamada Y, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148:397–401PubMedGoogle Scholar
  39. 39.
    Takayasu K, Moriyama N, Muramatsu Y, Suzuki M, Yamada T, Kishi K, Hasegawa H, Okazaki N (1984) Hepatic arterial embolization for hepatocellular carcinoma: Comparison of CT scans and resected specimens. Radiology 150:661–665PubMedGoogle Scholar
  40. 40.
    Kato T, Nemoto R, Mori H, Takahashi M, Tamakawa Y, Harada M (1981) Arterial chemoembolization with microencapsulated anticancer drug: An approach to selective cancer chemotherapy with sustained effects. JAMA 245:1123–1127PubMedCrossRefGoogle Scholar
  41. 41.
    Ohnishi K, Tsuchiya S, Nakayama T, Hiyama Y, Iwama S, Goto N, Takashi M, Kono K, Nakajima Y, Okuda K (1984) Arterial chemoembolization of hepatocellular carcinoma with mitomycin C microcapsules. Radiology 152:51–55PubMedGoogle Scholar
  42. 42.
    Iwatsuki S, Shaw BW, Starzl TE (1983) Experience with 150 liver resections. Ann Surg 197: 247–253PubMedCrossRefGoogle Scholar
  43. 43.
    Tang Z, Yu Y, Zhou X (1981) Factors influencing primary liver cancer resection survival rate. Chin Med J 94:749–754PubMedGoogle Scholar
  44. 44.
    Adson MA, Weiland LH (1981) Resection of primary solid hepatic tumors. Am J Surg 141: 18–21PubMedCrossRefGoogle Scholar
  45. 45.
    Lin TL (1976) Surgical treatment of primary liver cell carcinoma. In: Okuda K, Peters RL (eds) Wiley, New York, pp 449–468Google Scholar
  46. 46.
    Kanematsu T, Takenaka K, Matsumata T, Furuta T, Sugimachi K, Inokuchi K (1984) Limited hepatic resection effect for selected cir-rhotic patients with primary liver cancer. Ann Surg 199:51–56PubMedCrossRefGoogle Scholar
  47. 47.
    Nelson RS, DeElizalde R, Howe CD (1966) Clinical aspects of primary carcinoma of the liver. Cancer 19: 533–537PubMedCrossRefGoogle Scholar
  48. 48.
    Okazaki N (1976) Systemic chemotherapy of hepatocellular carcinoma. In: Okuda K, Peters RL (eds) Wiley, New York, pp 469–475Google Scholar
  49. 49.
    Link JS, Batemen JR, Paroly WS, Durkin WJ, Peters RL (1977) 5-Fluorouracil in hepatocellular carcinoma: Report of 21 cases. Cancer 39:1936–1939PubMedCrossRefGoogle Scholar
  50. 50.
    Vogel CL, Bayley AC, Borrker RJ, Anthony PP, Ziegler JL (1977) A phase II study of Adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States. Cancer 39:1923–1929PubMedCrossRefGoogle Scholar
  51. 51.
    Johnson PJ, Williams R, Thomas H, Sherlock S, Murray-Lyon IM (1978) Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet 1:1006–1009PubMedCrossRefGoogle Scholar
  52. 52.
    Olweny CLM, Katongole-Mbidde E, Bahendeka S, Otim D, Mugersa J, Kyalwazi SK (1980) Further experience in treating patients with hepatocellular carcinoma in Uganda. Cancer 46: 2717–2722PubMedCrossRefGoogle Scholar
  53. 53.
    Kubo Y, Shimokawa Y (1976) Arterial injection chemotherapy. In: Okuda K, Peters RL (eds). Wiley, New York, pp 477–490Google Scholar
  54. 54.
    Kinami Y, Miyazaki I (1978) The superselective and the selective one shot methods for treating inoperable cancer of the liver. Cancer 41:1720–1727PubMedCrossRefGoogle Scholar
  55. 55.
    Provan JL, Stokes JF, Edward D (1968) Hepatic artery infusion chemotherapy in hepatoma. Br Med J 3:346–349PubMedCrossRefGoogle Scholar
  56. 56.
    Al-Sarraf M, Go TS, Kithier K, Vaikevicius VK (1974) Primary liver cancer: A review of the clinical features, blood groups, serum enzymes, therapy, and survival of 65 cases. Cancer 33: 574–582PubMedCrossRefGoogle Scholar
  57. 57.
    Okuda K, Musha H, Nakajima Y, Kubo Y, Shimokawa Y, Nagasaki Y, Sawa Y, Jinnouchi S, Obata H, Hisamitsu T, Okazaki N, Kojiro M, Sakamoto K, Nakashima T (1977) Clinicopatho-logical features of encapsulated hepatocellular carcinoma: A study of 26 cases. Cancer 40:1240–1245PubMedCrossRefGoogle Scholar
  58. 58.
    Starzl TE, Iwatsuki S, Shaw BW Jr, Van Thiel DH, Gartner JC, Zitelli BJ, Malatack JJ, Schade RR (1984) Analysis of liver transplantation. Hepatology 4:47S–49SPubMedCrossRefGoogle Scholar
  59. 59.
    Rolles K, Williams R, Neuberger J, Calne R (1984) The Cambridge and King’s College Hospital experience of liver transplantation, 1968–1983. Hepatology 4: 50S–55SPubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 1987

Authors and Affiliations

  • Kunio Okuda
  • Kunihiko Ohnishi
    • 1
  1. 1.The First Department of MedicineChiba University School of MedicineInohana, Chiba, 280Japan

Personalised recommendations